Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | SHY-ONC6 |
| Synonyms | |
| Therapy Description |
SHY-ONC6 is a proteosome inhibitor that inhibits 19S regulatory particle ATPases, potentially resulting in induction of apoptosis and inhibition of tumor growth (Clin Cancer Res 2026;32(14_Suppl):Abstract nr B072). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| SHY-ONC6 | SHY ONC6|SHYONC6 | SHY-ONC6 is a proteosome inhibitor that inhibits 19S regulatory particle ATPases, potentially resulting in induction of apoptosis and inhibition of tumor growth (Clin Cancer Res 2026;32(14_Suppl):Abstract nr B072). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07705334 | Phase I | SHY-ONC6 | A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors (Luca-1) | Recruiting | USA | 0 |